ESSA Pharma Inc. (EPIX) Prices 7.1M Share Common Offering at $6/Sh

ESSA Pharma Inc. (NASDAQ: EPIX) today announced the pricing of an underwritten public offering of 7,100,000 common shares at a public offering price of US$6.00 per share, before underwriting discounts, for an aggregate offering of approximately US$42.6 million (the "Offering"). ESSA has granted the underwriters a 30-day option to purchase, in whole or in part, up to an additional 1,065,000 shares of its common shares (the "Option"). The proceeds to ESSA from the Offering are expected to be approximately US$39.0 million after deducting underwriting discounts and commissions and other estimated offering expenses but excluding any exercise of the Option. ESSA intends to use the net proceeds of the Offering for pre-clinical and clinical activities, chemistry, manufacturing and controls, research and development, as well as working capital and general corporate purposes. All common shares to be sold in the Offering will be offered by ESSA.

Jefferies is acting as sole book-running manager for the Offering. Oppenheimer & Co. is acting as lead manager for the Offering and Bloom Burton Securities Inc. is acting as co-manager for the Offering.

You May Also Be Interested In

• Csquare prices IPO at $21 per share on NYSE
• authID.ai (AUID) files for 4.64M share offering by selling stockholders
• Jefferies comments on reported Stripe-Advent bid for PayPal